Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jan 7, 2015; 21(1): 196-213
Published online Jan 7, 2015. doi: 10.3748/wjg.v21.i1.196
Table 2 Correlation between forkhead box protein M1 and E-cadherin expression and clinicopathological characteristics of hepatocellular carcinoma patients n (%)
VariablePatientsFOXM1 expression
P-valueE-cadherin expression
P-value
LowHighLowHigh
Gender
Male116 (67)48 (41)68 (59)0.18573 (63)43 (37)0.187
Female56 (33)17 (30)39 (70)29 (52)27 (48)
Age (yr)
≤ 5073 (42)24 (33)49 (67)0.27042 (58)31 (42)0.754
> 5099 (58)41 (41)58 (59)60 (61)39 (39)
Underlying liver disease
HBV133 (69)51 (38)82 (62)0.85280 (60)53 (40)0.713
Others39 (31)14 (36)25 (64)22 (56)17 (44)
Liver function (Child-Pugh classification)
Grade A157 (91)59 (38)98 (62)0.72093 (59)64 (41)0.913
Grade B11 (6)4 (36)7 (64)7 (64)4 (36)
Grade C4 (3)2 (50)2 (50)2 (50)2 (50)
Preoperative AFP level
≤ 200 ng/mL66 (42)19 (29)47 (71)0.09540 (61)26 (39)0.330
> 200 ng/mL90 (58)38 (42)52 (58)47 (52)43 (48)
Tumor size
≤ 8 cm116 (69)52 (45)64 (55)0.002a71 (61)45 (39)0.611
> 8 cm51 (31)10 (20)41 (80)29 (57)22 (43)
Tumor number
≤ 3157 (91)64 (40)93 (60)0.010a95 (61)62 (39)0.410
> 315 (9)1 (7)14 (93)7 (47)8 (53)
Cirrhotic background
No39 (23)11 (28)28 (72)0.19118 (46)21 (54)0.066
Yes133 (77)54 (41)79 (59)84 (63)49 (37)
Macrovascular invasion
No149 (87)63 (42)86 (58)0.002a82 (55)67 (45)0.003a
Yes23 (13)2 (9)21 (91)20 (87)3 (13)
Tumor differentiation
G1/G2154 (94)56 (34)98 (66)0.50287 (56)67 (44)0.047a
G310 (6)5 (80)5 (20)9 (90)1 (10)
TNM stage
Stage I + II135 (78)58 (43)77 (57)0.008a73 (53)62 (47)0.008a
Stage III (IIIA+IIIB+IIIC)37 (22)7 (19)30 (81)29 (78)8 (22)